000153 豐原藥業
按盤價 
6.440 -0.030 (-0.464%)
6.440 -0.030 (-0.464%) | 2025/09 - 九個月 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 4.867 | 8.229 | 8.805 | 8.900 | 7.795 |
| 總資產報酬率 ROA (%) | 2.075 | 3.539 | 3.595 | 3.622 | 3.196 |
| 投入資產回報率 ROIC (%) | 2.914 | 5.065 | 5.265 | 5.242 | 4.651 | 邊際利潤分析 |
| 銷售毛利率 (%) | 17.503 | 21.763 | 25.708 | 28.228 | 29.748 |
| 營業利潤率 (%) | 3.659 | 4.787 | 4.988 | 5.047 | 4.290 |
| 息稅前利潤/營業總收入 (%) | 4.400 | 5.547 | 5.629 | 5.799 | 5.428 |
| 淨利潤/營業總收入 (%) | 3.143 | 3.679 | 3.679 | 3.770 | 3.227 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 74.050 | 74.509 | 82.302 | 76.544 | 78.096 |
| 價值變動淨收益/利潤總額(%) | 8.729 | 1.886 | -0.735 | 7.327 | 6.087 |
| 營業外收支淨額/利潤總額(%) | -0.337 | 1.740 | 0.763 | 0.096 | 1.975 | 償債能力分析 |
| 流動比率 (X) | 0.908 | 0.898 | 0.945 | 0.886 | 0.964 |
| 速動比率 (X) | 0.656 | 0.627 | 0.660 | 0.588 | 0.627 |
| 資產負債率 (%) | 57.210 | 56.460 | 56.304 | 60.737 | 56.361 |
| 帶息債務/全部投入資本 (%) | 32.964 | 31.784 | 27.448 | 36.839 | 29.401 |
| 股東權益/帶息債務 (%) | 180.700 | 189.414 | 229.778 | 153.594 | 208.781 |
| 股東權益/負債合計 (%) | 73.935 | 76.123 | 76.417 | 63.677 | 76.136 |
| 利息保障倍數 (X) | 5.837 | 8.209 | 9.334 | 7.765 | 5.163 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 87.909 | 72.514 | 62.472 | 60.872 | 66.034 |
| 存貨周轉天數 (天) | 61.400 | 62.648 | 72.125 | 84.810 | 82.925 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 16/01/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
